Propofol Versus Dexmedetomidine for Sedation of Cancer Patients Undergoing ERCP

Clinical trial NCT06409104 · COMPLETED

Trial details

NCT number: NCT06409104
Sponsor: National Cancer Institute, Egypt
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sedation in ERCP

Start date: 2023-09-01
Primary completion: 2024-01-01
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.